SENSITIVITY OF HIPPOCAMPAL-NEURONS TO KAINIC ACID, AND ANTAGONISM BY KYNURENATE

被引:17
作者
STONE, TW
机构
基金
英国惠康基金;
关键词
D O I
10.1111/j.1476-5381.1990.tb14169.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The sensitivity to kainic acid of neurones in the CA1 and CA3 regions of rat hippocampal slices has been examined by microiontophoresis and by superfusion methods. 2. When the iontophoretic currents needed to produce comparable plateaux of firing were compared, neurones in the pyramidal cell layer of the CA3 region were approximately 5 times more sensitive than cells in the CA1 region. No difference was noted in sensitivity to N-methyl-D-aspartate (NMDA) or quisqualate. 3. When kainate was superfused at known concentrations, the threshold for eliciting excitation in CA1 was 2.1 μM. The threshold concentration in CA3 was 0.24 μM. 4. Two weeks after the stereotaxic intrahippocampal injection of colchicine, the granule cells of the dentate gyrus and thus the mossy fibre projections to CA3 were destroyed. In slices prepared from animals thus treated the threshold concentration of kainate for eliciting excitation had risen to 1.64 μM. 5. Kainate was less effective in promoting the development of epileptiform bursts of neuronal firing in colchicine-treated slices than in controls. 6. Kynurenic acid antagonized the excitation of CA1 neurones elicited by kainate, NMDA or quisqualate. In the CA3 region kynurenate antagonized selectively responses to microiontophoretic NMDA, with little effect on responses to kainate or quisqualate. 7. In slices taken from colchicine-treated rats kynurenate was able to block responses to kainate in the CA3 area in parallel with responses to NMDA. 8. Taken together the results suggest that the excitatory responses to kainate in the CA3 region may be partly due to a presynaptic action on mossy fibre terminals to release endogenous amino acids. The differential action of kynurenate in normal and lesioned slices may, therefore, indicate that the postsynaptic kainate receptors are sensitive to antagonism by this compound whereas the presynaptic receptors are resistant to kynurenate.
引用
收藏
页码:847 / 852
页数:6
相关论文
共 45 条
[1]   KYNURENIC ACID ANTAGONISES RESPONSES TO NMDA VIA AN ACTION AT THE STRYCHNINE-INSENSITIVE GLYCINE RECEPTOR [J].
BIRCH, PJ ;
GROSSMAN, CJ ;
HAYES, AG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 154 (01) :85-87
[2]   PRE-SYNAPTIC KAINATE AND N-METHYL-D-ASPARTATE RECEPTORS REGULATE EXCITATORY AMINO-ACID RELEASE IN THE OLFACTORY CORTEX [J].
COLLINS, GGS ;
ANSON, J ;
SURTEES, L .
BRAIN RESEARCH, 1983, 265 (01) :157-159
[3]   QUINOLINIC ACID EFFECTS ON AMINO-ACID RELEASE FROM THE RAT CEREBRAL-CORTEX INVITRO AND INVIVO [J].
CONNICK, JH ;
STONE, TW .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (04) :868-876
[4]   KYNURENATE AND 2-AMINO-5-PHOSPHONOVALERATE INTERACT WITH MULTIPLE BINDING-SITES OF THE N-METHYL-D-ASPARTATE-SENSITIVE GLUTAMATE RECEPTOR DOMAIN [J].
DANYSZ, W ;
FADDA, E ;
WROBLEWSKI, JT ;
COSTA, E .
NEUROSCIENCE LETTERS, 1989, 96 (03) :340-344
[5]   REDUCED EXCITATORY EFFECT OF KAINIC ACID ON RAT CA3 HIPPOCAMPAL PYRAMIDAL NEURONS FOLLOWING DESTRUCTION OF THE MOSSY PROJECTION WITH COLCHICINE [J].
DEMONTIGNY, C ;
WEISS, M ;
OUELLETTE, J .
EXPERIMENTAL BRAIN RESEARCH, 1987, 65 (03) :605-613
[6]   DIFFERENTIAL EXCITATORY EFFECTS OF KAINIC ACID ON CA3 AND CA1 HIPPOCAMPAL PYRAMIDAL NEURONS - FURTHER EVIDENCE FOR THE EXCITOTOXIC HYPOTHESIS AND FOR A RECEPTOR-MEDIATED ACTION [J].
DEMONTIGNY, C ;
TARDIF, D .
LIFE SCIENCES, 1981, 29 (20) :2103-2111
[7]   THE ACTIONS OF CHOLECYSTOKININ AND RELATED PEPTIDES ON PYRAMIDAL NEURONS OF THE MAMMALIAN HIPPOCAMPUS [J].
DODD, J ;
KELLY, JS .
BRAIN RESEARCH, 1981, 205 (02) :337-350
[8]   EFFECTS OF KYNURENATE ON ROOT POTENTIALS-EVOKED BY SYNAPTIC ACTIVITY AND AMINO-ACIDS IN THE FROG SPINAL-CORD [J].
ELMSLIE, KS ;
YOSHIKAMI, D .
BRAIN RESEARCH, 1985, 330 (02) :265-272
[9]   A COMPARISON OF EXCITATORY AMINO-ACID ANTAGONISTS ACTING AT PRIMARY AFFERENT C-FIBERS AND MOTONEURONS OF THE ISOLATED SPINAL-CORD OF THE RAT [J].
EVANS, RH ;
EVANS, SJ ;
POOK, PC ;
SUNTER, DC .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 91 (03) :531-537
[10]  
FERKANY JW, 1983, J PHARMACOL EXP THER, V225, P399